BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30076450)

  • 1. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
    Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
    Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
    Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
    Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
    Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of
    Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 L-3,4-dihydroxyphenylalanine positron emission tomography: improving surgery and outcome in focal hyperinsulinism. Commentary to Mohnike et al.: Proposal for a standardized protocol for F-DOPA-PET (PET/CT) in congenital hyperinsulinism (Horm Res 2006;66:40-42).
    Shield JP
    Horm Res; 2006; 66(1):43-4. PubMed ID: 16710095
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.
    Ismail D; Hussain K
    Rev Endocr Metab Disord; 2010 Sep; 11(3):165-9. PubMed ID: 20878481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
    Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
    Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
    Subramaniam RM; Karantanis D; Peller PJ
    J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
    Garg PK; Putegnat B; Truong L; Reynolds C; Sanchez I; Nedrelow JK; Uffman J; Lokitz SJ; Nazih R; Garg S; Thornton PS
    PLoS One; 2020; 15(10):e0241243. PubMed ID: 33108363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
    Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital hyperinsulinism: localization of a focal lesion with
    States LJ; Becker SA; De León DD
    Pediatr Radiol; 2022 Apr; 52(4):693-701. PubMed ID: 34668049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.
    Mohnike K; Blankenstein O; Christesen HT; De Lonlay J; Hussain K; Koopmans KP; Minn H; Mohnike W; Mutair A; Otonkoski T; Rahier J; Ribeiro M; Schoenle E; Fékété CN
    Horm Res; 2006; 66(1):40-2. PubMed ID: 16710094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.